Prof. Dr. Sven Vanneste
Prof. Sven Vanneste, PhD, is an internationally renowned neuroscientist specializing in the functioning of brain networks, neuroplasticity, and neuromodulation. He isChair of Clinical Neuroscience and Head of the School of Psychology atTrinity College Dublin, where he also leads theLab for Clinical & Integrative Neuroscience (CLINT).
His research focuses on a fundamental question:
"How do neurological and psychiatric symptoms arise from changes in the activity and interaction of brain networks, and how can we target these networks to influence them?"
Using advanced brain imaging, EEG, computational modeling, and both invasive and non-invasive neuromodulation, he investigates the mechanisms behind conditions such astinnitus,chronic pain,depression,addiction,cognitive disordersandstress-related conditions.
A key part of his work is the development of objective biomarkers and personalized treatment approaches. In doing so, he seeks to better understand why patients with the same diagnosis experience different symptoms and why they do not always respond to treatments in the same way.
Prof. Vanneste is the author or co-author of more than 300 scientific publications in international journals:
- The Lancet
- Nature Reviews Neuroscience
- Nature Communications
- Science Advances
- Science Translational Medicine.
His scientific work can be found viaPubMedand hisORCID research profile.
He holds various international scientific positions, including the chairmanship of theTinnitus Detection (TIDE) Consortium, which conducts research into the objective detection of tinnitus.
Before his appointment at Trinity College Dublin, he was affiliated with theUniversity of Texas at Dallas. In addition, he is an honorary research professor at theUniversity of Otago in New Zealand.
Asco-founder of BRAI3N, together with Prof. Dirk De Ridder and Jan Ost, he is committed to strengthening the bridge between fundamental neuroscience research and clinical patient care.
His scientific vision forms an important foundation for the development and critical evaluation of neuromodulation within BRAI3N.
More about his scientific career: Global Brain Health Institute.
